Daily Stock Analysis, CDXS, Codexis Inc, priceseries

Codexis Inc. Daily Stock Analysis
Stock Information
Open
21.46
Close
21.79
High
21.90
Low
21.46
Previous Close
21.45
Daily Price Gain
0.34
YTD High
22.49
YTD High Date
Feb 13, 2019
YTD Low
15.43
YTD Low Date
Jan 14, 2019
YTD Price Change
5.68
YTD Gain
35.26%
52 Week High
23.05
52 Week High Date
Dec 3, 2018
52 Week Low
8.60
52 Week Low Date
Feb 15, 2018
52 Week Price Change
12.99
52 Week Gain
147.61%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 7. 2017
6.85
Jan 3. 2018
8.10
17 Trading Days
18.31%
Link
LONG
Feb 14. 2018
8.65
Mar 9. 2018
10.00
16 Trading Days
15.61%
Link
LONG
May 11. 2018
12.65
Jun 8. 2018
14.75
19 Trading Days
16.61%
Link
LONG
Aug 17. 2018
15.05
Sep 19. 2018
17.89
22 Trading Days
18.84%
Link
LONG
Nov 21. 2018
17.42
Dec 11. 2018
20.82
12 Trading Days
19.52%
Link
Company Information
Stock Symbol
CDXS
Exchange
NasdaqGS
Company URL
http://www.codexis.com
Company Phone
650-421-8100
CEO
John J. Nicols
Headquarters
California
Business Address
200 PENOBSCOT DRIVE, REDWOOD CITY, CA 94063
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001200375
About

Codexis, Inc. is a protein engineering company, which applies its technology to the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. The company discovers, develops and sells proteins that deliver value to its clients in a growing set of industries. It provides state-of-the-art enzyme optimization services and developing biocatalyst products. The company's technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. It offers enzyme optimization and supply, from small scale through to commercial quantities. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Description

Codexis, Inc. discovers, develops, and sells protein catalysts. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also improves the pharmaceuticals companies manufacturing productivity and efficiency, as well as helps in outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. Further, the company develops biocatalysts for use in the fine chemicals market, including food and food ingredients, animal feed, flavors and fragrances, and agricultural chemicals. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.